Brain+ A/S (CPH:BRAINP)
Denmark · Delayed Price · Currency is DKK 0.0032
-0.0002 (-6.25%)
Feb 13, 2026, 11:55 AM CET
Brain+ Market Cap
Brain+ has a market cap or net worth of 3.63 million as of February 13, 2026. Its market cap has decreased by -79.93% in one year.
Market Cap
3.63M
Enterprise Value
-718.27K
Revenue
5.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 3.63M, a decrease of -93.03%. That is a compound annual growth rate of -45.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 3.40M | -70.00% |
| Dec 30, 2025 | 11.33M | -43.17% |
| Dec 30, 2024 | 19.94M | 56.98% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
| Oct 7, 2021 | 51.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.40T |
| Genmab | 119.38B |
| Coloplast | 110.76B |
| ALK-Abelló | 48.22B |
| BioPorto | 491.14M |
| Pharma Equity Group | 130.73M |
| ViroGates | 109.06M |
| Scandinavian Medical Solutions | 106.50M |